Study

NOWAC blood-based breast cancer case-control study

Study ID Alternative Stable ID Type
EGAS00000000134 Expression array/Phenotype

Study Description

Tumor-host interactions extend beyond the local microenvironment and cancer development largely depends on the ability of malignant cells to hijack and exploit the normal physiological processes of the host. Although abnormalities in a host’s systemic immunity are associated with increased cancer susceptibility, the functional interplay between tumor cells and circulating immune cells in regulating tumorigenic responses is unclear. We employed the Norwegian Women and Cancer study, a large prospective population-based cohort study, to identify gene expression changes in blood cells that provide a robust and reproducible diagnostic signal specific to breast cancer patients. We further show that circulating blood cells in breast cancer patients are enriched in genes involved in systemic immunosuppression and the motility, metabolism, growth, and proliferation of immune cells. By mining of the cancer-associated blood transcriptome, we identified immune mediators or biomarkers that could permit early detection of breast cancer and open avenues to novel targeted immunotherapies.

Study Datasets 3 datasets.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00010000474
blood-based gene expression from breast cancer cases and age-matched controls in case-control serie 2 (CC2)
Illumina 98
EGAD00010000476
blood-based gene expression from breast cancer cases and age-matched controls in case-control serie 1 (CC1)
Illumina 110
EGAD00010000478
blood-based gene expression from breast cancer cases and age-matched controls in case-control serie 3 (CC3)
Illumina 118

Who archives the data?

Publications

Citations

Retrieving...
Retrieving...